Clinical Fellow in Medicine, Dana-Farber Cancer Institute
Hematology
Dr. Priscilla K. Brastianos, MD
|
|
Give Review
Priscilla Brastianos works in the field of Hematology. She went to Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a one of the best medicals schools. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine Dr. Priscilla K. Brastianos has written publications. She has 21 publications published with PubMed. The lastest paper is: 'A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus.' She accepts Medicare payments and is registered with Medicare.gov.
Publications
- Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.
- BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histology.
- PLEKHA5: A Key to Unlock the Blood-Brain Barrier?
- Alectinib Salvages CNS Metastases in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib.
- Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S.
- Turner syndrome and meningioma: Support for a possible increased risk of neoplasia in Turner syndrome.
- Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.
- Clinical discussion and review of the management of brain metastases.
- Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.
- Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
- Primary central nervous system lymphoma: overview of current treatment strategies.
- The toxicity of intrathecal bevacizumab in a rabbit model of leptomeningeal carcinomatosis.
- Prognostic and predictive value of epigenetic silencing of MGMT in patients with high grade gliomas: a systematic review and meta-analysis.
- Wiped out.
- VEGF inhibitors in brain tumors.
- Tuberculosis-associated haemophagocytic syndrome.
- Sporadic hemangioblastomas are characterized by cryptic VHL inactivation.
- Radiation Treatment for WHO Grade II and III Meningiomas.
- A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus.
- Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Relapsing on Stand...
Schools
Johns Hopkins University School of Medicine
Conditions Treated
- Anemia
Doctors Specialties
- Hematology
Accepted Insurances
Education
-
Brigham and Women's Hospital -
Johns Hopkins University -
Johns Hopkins University School of Medicine
Hospital
-
Massachusetts General Hospital -
Dana-Farber Cancer Institute
Drug Facts
| NPI NUMBER | 1508906355 | |
| NPPES Provider LastName | BRASTIANOS | |
| NPPES Provider FirstName | PRISCILLA | |
| NPPES Provider ZIPCode | 021142621 | |
| NPPES Provider State | MA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 30.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1508906355 |
| Last Name Of The Provider | BRASTIANOS |
| First Name Of The Provider | PRISCILLA |
| View All |
Similar Doctors
|
|
Dr. Kathleen M. Mahoney, MD |
|
|
Dr. Lillian E. McMahon, MD
 This Doctor is OpenDoctor Recommended.
|